Evidence and support

Blueberry, tryptophan and tyrosine: primary versus exploratory findings

A randomized trial of a supplement combination missed its primary mood-induction endpoint. An exploratory postpartum-blues score improved. That distinction is central to interpreting the claim.

Research preview · selected sources rechecked September 14, 2026 · independent clinical review pending. These editorial assessments are not formal GRADE ratings. No study here establishes an effect of Brighter Postpartum.

The important distinction

Baby blues is not the same outcome as diagnosed postpartum depression. Timing around the first days after birth does not justify a DIY high-dose amino-acid protocol. Conflicts of interest also matter.

limitedprevention · C19

Amino-acid/blueberry product: negative primary, positive exploratory result

Population and setting: 103 early-postpartum participants in the main analyzed groups.
What was found: No primary mood-induction effect; exploratory baby-blues score favored supplementation (effect size 0.62).
Limits and applicability: Baby blues is not PPD. Inventor/commercial conflicts disclosed. Do not supply a DIY dosing protocol or imply breastfeeding safety from this trial.

Sources: S30

Is this a proven prevention product?

No. The finding does not establish prevention or cure of PPD, and lactation safety cannot be assumed from a positive exploratory score.

Use this as information, not an assessment

Symptoms or concerns deserve appropriate professional care. Severe or worsening symptoms should not wait for an app, a quiz or a two-week threshold.